NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-120-2003-1-FR-09 Method of Inducing Memory B Cell Development and Terminal Differentiation FR EP 04811794.9 Expired
NHLBI E-120-2003-1-DK-08 Method of Inducing Memory B Cell Development and Terminal Differentiation DK EP 04811794.9 Expired
NCI E-056-2002-0-US-03 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAMEWORK US National Stage 10/515,149 7456260 Abandoned PDF
NCI E-281-2008-0-US-03 Novel Lamda Phagc Display System And The Process US National Stage 10/515,150 7410801 Abandoned PDF
NCI E-124-1996-0-US-06 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE 1 AND RELATED COMPOSITIONS AND METHODS US DIV 10/993,191 7297493 Expired PDF
NHLBI E-120-2003-1-GB-04 Method of Inducing Memory B Cell Development and Terminal Differentiation GB National Stage 0609952.7 Expired
NHLBI E-120-2003-1-PCT-02 Method of Inducing Memory B Cell Development and Terminal Differentiation PCT PCT PCT/US2004/039135 Expired
NCI E-037-2004-0-PCT-02 TARGETED CONJUGATES WITH A MODIFIED SACCHARIDE LINKER PCT PCT PCT/US2004/038781 Expired
NCI E-203-2004-0-US-01 Improved Replication-Competent Adenoviral Vectors US 60/629,722 Abandoned
NEI E-094-2003-0-US-01 Formulation Of Triamcinolone Acetonide Suspension For Intravitreal Delivery By Injection US 60/628,741 Abandoned
NIAID E-031-2004-2-JP-06 Anti-Tubercular Drug: Compositions And Methods JP National Stage 2004-504988 Expired
NCI E-190-2002-2-US-02 Identification of a Novel (BHD) Gene US National Stage 10/514,744 7485709 Abandoned PDF
NCI E-065-2002-0-US-03 ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma US National Stage 10/514,910 Abandoned
NIEHS E-103-2000-2-US-01 New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use71 US 60/628,147 Abandoned
NLM E-111-2004-0-PCT-02 Methods, Articles, And Compositions For Identifying Oligonucleotides PCT PCT PCT/US2004/038092 Expired
NCI E-087-2005-0-EP-06 Custom Vectors for Treating and Preventing Pancreatic Cancer EP National Stage 04811370.8 Expired
NCI E-087-2005-0-CA-05 Custom Vectors for Treating and Preventing Pancreatic Cancer CA National Stage 2545183 Expired
NCI E-088-2005-0-CA-05 System for Treating and Preventing Breast Cancer CA National Stage 2545164 Expired
NCI E-088-2005-0-ES-16 System for Treating and Preventing Breast Cancer ES EP 04810831.0 Expired
NCI E-088-2005-0-GB-18 System for Treating and Preventing Breast Cancer GB EP 04810831.0 Expired
NCI E-088-2005-0-CH-13 System for Treating and Preventing Breast Cancer CH EP 04810831.0 Expired
NCI E-088-2005-0-SE-21 System for Treating and Preventing Breast Cancer SE EP 04810831.0 Expired
NCI E-088-2005-0-BE-12 System for Treating and Preventing Breast Cancer BE EP 04810831.0 Expired
NCI E-088-2005-0-AT-11 System for Treating and Preventing Breast Cancer AT EP 04810831.0 Expired
NCI E-088-2005-0-DE-14 System for Treating and Preventing Breast Cancer DE EP 04810831.0 Expired
NCI E-088-2005-0-DK-15 System for Treating and Preventing Breast Cancer DK EP 04810831.0 Expired
NCI E-088-2005-0-FR-17 System for Treating and Preventing Breast Cancer FR EP 04810831.0 Expired
NCI E-088-2005-0-IT-19 System for Treating and Preventing Breast Cancer IT EP 04810831.0 Expired
NCI E-088-2005-0-NL-20 System for Treating and Preventing Breast Cancer NL EP 04810831.0 Expired
NCI E-088-2005-0-EP-06 System for Treating and Preventing Breast Cancer EP National Stage 04810831.0 Expired
NCI E-087-2005-0-JP-07 Custom Vectors for Treating and Preventing Pancreatic Cancer JP National Stage 2006-540033 Expired
NCI E-088-2005-0-JP-07 System for Treating and Preventing Breast Cancer JP National Stage 2006-539904 Expired
NCI E-088-2005-0-AU-04 System for Treating and Preventing Breast Cancer AU National Stage 2004289340 Expired
NCI E-087-2005-0-AU-04 Custom Vectors for Treating and Preventing Pancreatic Cancer AU National Stage 2004289368 Expired
NICHD E-158-1998-0-US-07 VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION US DIV 10/987,428 7553490 Abandoned PDF
NCI E-087-2005-0-PCT-02 Custom Vectors for Treating and Preventing Pancreatic Cancer PCT PCT PCT/US2004/38643 Expired
NCI E-088-2005-0-PCT-02 System for Treating and Preventing Breast Cancer PCT PCT PCT/US2004/037810 Expired
NICHD E-207-1999-2-US-02 Recombinant Toxin A Proten Carrier For Polysaccride Conjugate Vaccines US CON 10/987,508 Abandoned
NCI E-167-1999-0-US-05 Utilization of FPRL1 as a Functional Receptor by Serum Amyloid A (SAA) US CON 10/987,664 Abandoned
NCI E-088-2005-0-JP-09 System for Treating and Preventing Breast Cancer JP DIV 2011-179768 Abandoned
NCI E-065-2010-0-US-01 Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume US 60/626,947 Abandoned
NCI E-017-2002-0-US-06 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS US National Stage 10/513,961 7491798 Abandoned PDF
NIAMS E-277-2003-0-PCT-02 Absence Of Gamma Delta T-Cells Confers Stability In Fracture Healing PCT PCT PCT/US2004/37287 Expired
NCI E-189-2002-0-US-06 POLYDIAZENIUMDIOLATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND METHODS OF USING SAME US National Stage 10/982,576 7468435 Abandoned PDF
NCI E-138-2007-0-US-01 Methods For Preparing Cells And Viruses US 60/625,321 Abandoned
CC E-278-2004-0-US-01 Access System for Tissue Ablation Device US 60/625,186 Abandoned
NIAID E-089-2002-1-JP-06 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4 JP National Stage 2004-500777 Expired
NIAID E-201-2000-0-US-04 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US CON 10/982,223 7622123 Expired PDF
NHLBI E-060-2004-0-PCT-02 ESTROGEN RECEPTOR ALPHA GENE VARIATION AND DISEASE PCT PCT PCT/US2004/037209 Expired
NHLBI E-060-2004-0-US-03 ESTROGEN RECEPTOR GENE VARIATION AND DISEASE US National Stage 10/982,726 Abandoned